Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.50 |
| ▸ | F11 | P03951 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 6/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 4/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28067255 | 0.98 | ST14 (0.48) | ST14F11ABATHRH3MAOB | |
| Hydrochloric Acid SCHEMBL3457459 | 0.98 | F11 (0.54) | ST14F11ABATHRH3MAOB | |
| SCHEMBL28069904 | 0.94 | HRH3 (0.56) | ST14F11ABATHRH3MAOB | |
| SCHEMBL29278208 | 0.89 | ST14 (0.41) | ST14F11ABATHRH3MAOB | |
| SCHEMBL29112149 | 0.83 | TAAR1 (0.55) | MAOB | |
| SCHEMBL3800806 | 0.80 | CA1 (0.38) | — | |
| SCHEMBL29643534 | 0.79 | ENPP2 (0.48) | ST14F11MAOBLOXL2F10 | |
| SCHEMBL27569009 | 0.79 | ENPP2 (0.48) | ST14F11MAOBLOXL2F10 | |
| SCHEMBL1251529 | 0.79 | LTA4H (0.50) | HRH3 | |
| Hydrochloric Acid SCHEMBL28156681 | 0.78 | ENPP2 (0.47) | F11MAOBLOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115873246-B | High-temperature-resistant high-solidity supermolecule shape memory polyimide and preparation method thereof | 中国科学院兰州化学物理研究所 | 2024-06-07 | — | — | CN | claimed |
| CN-117986571-A | Hyperbranched poly (beta-amino ester) with different groups at tail ends, and preparation method and application thereof | 西安交通大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117771185-A | Layered targeting dual delivery system based on photo-immunotherapy and preparation method and application thereof | 贵州医科大学 | 2024-03-29 | — | — | CN | claimed |
| CN-116973436-A | Mass spectrum imaging detection method for compound containing ortho-diphenol hydroxyl functional group in tissue | 中国科学院大连化学物理研究所 | 2023-10-31 | — | — | CN | claimed |
| US-4264738-A | ABSORPTION BY THE PRODUCT OF AN AMINO DERIVATIVE OF A SILICEOUS MATERIAL, A CONDENSATION AGENT, AND A LIGAND | STEPANOV VALENTIN M | 1981-04-28 | — | — | US | claimed |
| CN-114716381-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-114605327-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-114573510-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-111699189-B | Modulators of beta-3 adrenergic receptors useful for treating or preventing heart failure and disorders associated therewith | 艾尼纳制药公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-114591242-B | Compounds useful as kinase inhibitors | 洛克索肿瘤学股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-119241532-A | 1H-pyrazolo [4,3-c ] pyridine compound, composition and application thereof | 深圳市塔吉瑞生物医药有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119173267-A | Surface-modified nanodiamond | 国立大学法人京都大学 | 2024-12-20 | — | — | CN | disclosed |
| CN-1285601-C | Light emitting device and display | CANON KK (JP) | 2006-11-22 | — | — | CN | disclosed |
| US-20060167053-A1 | Heteroarylcarbamoylbenzene derivative | MSD K.K. (JP) | 2006-07-27 | — | — | US | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
| EP-1600442-A1 | HETEROARYLCARBAMOYLBENZENE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-11-30 | — | — | EP | disclosed |
| CN-1670942-A | Dicing die-bonding film | NITTO DENKO CORP (JP) | 2005-09-21 | — | — | CN | disclosed |
| CN-1208360-C | In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes | SUMITOMO BAKELITE CO (JP) | 2005-06-29 | — | — | CN | disclosed |
| CN-1343206-A | Cyclocompound | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-04-03 | — | — | CN | disclosed |
| US-4264738-A | ABSORPTION BY THE PRODUCT OF AN AMINO DERIVATIVE OF A SILICEOUS MATERIAL, A CONDENSATION AGENT, AND A LIGAND | STEPANOV VALENTIN M | 1981-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060167053-A1 | Heteroarylcarbamoylbenzene derivative | GCK, GCKR, GALK1 | ST14 2354/4885F11 4015/4885ABAT 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.